Literature DB >> 33627311

Excess mortality in Wuhan city and other parts of China during the three months of the covid-19 outbreak: findings from nationwide mortality registries.

Jiangmei Liu1, Lan Zhang2, Yaqiong Yan3, Yuchang Zhou4, Peng Yin1, Jinlei Qi1, Lijun Wang1, Jingju Pan2, Jinling You1, Jing Yang1, Zhenping Zhao1, Wei Wang1, Yunning Liu1, Lin Lin1, Jing Wu1, Xinhua Li5, Zhengming Chen6, Maigeng Zhou4.   

Abstract

OBJECTIVE: To assess excess all cause and cause specific mortality during the three months (1 January to 31 March 2020) of the coronavirus disease 2019 (covid-19) outbreak in Wuhan city and other parts of China.
DESIGN: Nationwide mortality registries.
SETTING: 605 urban districts and rural counties in China's nationally representative Disease Surveillance Point (DSP) system. PARTICIPANTS: More than 300 million people of all ages. MAIN OUTCOME MEASURES: Observed overall and weekly mortality rates from all cause and cause specific diseases for three months (1 January to 31 March 2020) of the covid-19 outbreak compared with the predicted (or mean rates for 2015-19) in different areas to yield rate ratio.
RESULTS: The DSP system recorded 580 819 deaths from January to March 2020. In Wuhan DSP districts (n=3), the observed total mortality rate was 56% (rate ratio 1.56, 95% confidence interval 1.33 to 1.87) higher than the predicted rate (1147 v 735 per 100 000), chiefly as a result of an eightfold increase in deaths from pneumonia (n=1682; 275 v 33 per 100 000; 8.32, 5.19 to 17.02), mainly covid-19 related, but a more modest increase in deaths from certain other diseases, including cardiovascular disease (n=2347; 408 v 316 per 100 000; 1.29, 1.05 to 1.65) and diabetes (n=262; 46 v 25 per 100 000; 1.83, 1.08 to 4.37). In Wuhan city (n=13 districts), 5954 additional (4573 pneumonia) deaths occurred in 2020 compared with 2019, with excess risks greater in central than in suburban districts (50% v 15%). In other parts of Hubei province (n=19 DSP areas), the observed mortality rates from pneumonia and chronic respiratory diseases were non-significantly 28% and 23% lower than the predicted rates, despite excess deaths from covid-19 related pneumonia. Outside Hubei (n=583 DSP areas), the observed total mortality rate was non-significantly lower than the predicted rate (675 v 715 per 100 000), with significantly lower death rates from pneumonia (0.53, 0.46 to 0.63), chronic respiratory diseases (0.82, 0.71 to 0.96), and road traffic incidents (0.77, 0.68 to 0.88).
CONCLUSIONS: Except in Wuhan, no increase in overall mortality was found during the three months of the covid-19 outbreak in other parts of China. The lower death rates from certain non-covid-19 related diseases might be attributable to the associated behaviour changes during lockdown. © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Mesh:

Year:  2021        PMID: 33627311      PMCID: PMC7900645          DOI: 10.1136/bmj.n415

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  31 in total

1.  COVID-19 and the Heart.

Authors:  Akbarshakh Akhmerov; Eduardo Marbán
Journal:  Circ Res       Date:  2020-04-07       Impact factor: 17.367

Review 2.  COVID-19 and Cardiovascular Disease.

Authors:  Kevin J Clerkin; Justin A Fried; Jayant Raikhelkar; Gabriel Sayer; Jan M Griffin; Amirali Masoumi; Sneha S Jain; Daniel Burkhoff; Deepa Kumaraiah; LeRoy Rabbani; Allan Schwartz; Nir Uriel
Journal:  Circulation       Date:  2020-03-21       Impact factor: 29.690

3.  An improved algorithm for outbreak detection in multiple surveillance systems.

Authors:  Angela Noufaily; Doyo G Enki; Paddy Farrington; Paul Garthwaite; Nick Andrews; André Charlett
Journal:  Stat Med       Date:  2012-09-02       Impact factor: 2.373

Review 4.  Contrasting male and female trends in tobacco-attributed mortality in China: evidence from successive nationwide prospective cohort studies.

Authors:  Zhengming Chen; Richard Peto; Maigeng Zhou; Andri Iona; Margaret Smith; Ling Yang; Yu Guo; Yiping Chen; Zheng Bian; Garry Lancaster; Paul Sherliker; Shutao Pang; Hao Wang; Hua Su; Ming Wu; Xianping Wu; Junshi Chen; Rory Collins; Liming Li
Journal:  Lancet       Date:  2015-10-10       Impact factor: 79.321

5.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.

Authors:  Qun Li; Xuhua Guan; Peng Wu; Xiaoye Wang; Lei Zhou; Yeqing Tong; Ruiqi Ren; Kathy S M Leung; Eric H Y Lau; Jessica Y Wong; Xuesen Xing; Nijuan Xiang; Yang Wu; Chao Li; Qi Chen; Dan Li; Tian Liu; Jing Zhao; Man Liu; Wenxiao Tu; Chuding Chen; Lianmei Jin; Rui Yang; Qi Wang; Suhua Zhou; Rui Wang; Hui Liu; Yinbo Luo; Yuan Liu; Ge Shao; Huan Li; Zhongfa Tao; Yang Yang; Zhiqiang Deng; Boxi Liu; Zhitao Ma; Yanping Zhang; Guoqing Shi; Tommy T Y Lam; Joseph T Wu; George F Gao; Benjamin J Cowling; Bo Yang; Gabriel M Leung; Zijian Feng
Journal:  N Engl J Med       Date:  2020-01-29       Impact factor: 176.079

6.  A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.

Authors:  Jasper Fuk-Woo Chan; Shuofeng Yuan; Kin-Hang Kok; Kelvin Kai-Wang To; Hin Chu; Jin Yang; Fanfan Xing; Jieling Liu; Cyril Chik-Yan Yip; Rosana Wing-Shan Poon; Hoi-Wah Tsoi; Simon Kam-Fai Lo; Kwok-Hung Chan; Vincent Kwok-Man Poon; Wan-Mui Chan; Jonathan Daniel Ip; Jian-Piao Cai; Vincent Chi-Chung Cheng; Honglin Chen; Christopher Kim-Ming Hui; Kwok-Yung Yuen
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

7.  Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study.

Authors:  Joseph T Wu; Kathy Leung; Gabriel M Leung
Journal:  Lancet       Date:  2020-01-31       Impact factor: 79.321

8.  Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020.

Authors:  Julien Riou; Christian L Althaus
Journal:  Euro Surveill       Date:  2020-01

Review 9.  The First 75 Days of Novel Coronavirus (SARS-CoV-2) Outbreak: Recent Advances, Prevention, and Treatment.

Authors:  Yuxin Yan; Woo In Shin; Yoong Xin Pang; Yang Meng; Jianchen Lai; Chong You; Haitao Zhao; Edward Lester; Tao Wu; Cheng Heng Pang
Journal:  Int J Environ Res Public Health       Date:  2020-03-30       Impact factor: 3.390

10.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

Authors:  Fei Zhou; Ting Yu; Ronghui Du; Guohui Fan; Ying Liu; Zhibo Liu; Jie Xiang; Yeming Wang; Bin Song; Xiaoying Gu; Lulu Guan; Yuan Wei; Hui Li; Xudong Wu; Jiuyang Xu; Shengjin Tu; Yi Zhang; Hua Chen; Bin Cao
Journal:  Lancet       Date:  2020-03-11       Impact factor: 79.321

View more
  32 in total

1.  Excess Mortality During the COVID-19 Pandemic in Guatemala.

Authors:  Kevin Martinez-Folgar; Diego Alburez-Gutierrez; Alejandra Paniagua-Avila; Manuel Ramirez-Zea; Usama Bilal
Journal:  Am J Public Health       Date:  2021-09-23       Impact factor: 11.561

2.  Co-Infections, Secondary Infections, and Antimicrobial Use in Patients Hospitalized with COVID-19 during the First Five Waves of the Pandemic in Pakistan; Findings and Implications.

Authors:  Kiran Ramzan; Sameen Shafiq; Iqra Raees; Zia Ul Mustafa; Muhammad Salman; Amer Hayat Khan; Johanna C Meyer; Brian Godman
Journal:  Antibiotics (Basel)       Date:  2022-06-09

3.  Public anxiety through various stages of COVID-19 coping: Evidence from China.

Authors:  Yangyang Wu; Ting Zhang; Ziwen Ye; Kai Chen; J van der Kuijp; Xue Sun; Guoyi Han; Yi Zhao; Yang Liu; Lei Huang
Journal:  PLoS One       Date:  2022-06-16       Impact factor: 3.752

4.  Trust in Institutions, Not in Political Leaders, Determines Compliance in COVID-19 Prevention Measures within Societies across the Globe.

Authors:  Ryan P Badman; Ace X Wang; Martin Skrodzki; Heng-Chin Cho; David Aguilar-Lleyda; Naoko Shiono; Seng Bum Michael Yoo; Yen-Sheng Chiang; Rei Akaishi
Journal:  Behav Sci (Basel)       Date:  2022-05-30

5.  How Policy Mix Choices Affect the COVID-19 Pandemic Response Outcomes in Chinese Cities: An Empirical Analysis.

Authors:  Chunyu Shi; Tao Xu; Zhihang Ying; Huan Li
Journal:  Int J Environ Res Public Health       Date:  2022-07-01       Impact factor: 4.614

6.  Temporal dynamic in the impact of COVID- 19 outbreak on cause-specific mortality in Guangzhou, China.

Authors:  Li Li; Dong Hang; Han Dong; Chen Yuan-Yuan; Liang Bo-Heng; Yan Ze-Lin; Yang Zhou; Ou Chun-Quan; Qin Peng-Zhe
Journal:  BMC Public Health       Date:  2021-05-08       Impact factor: 3.295

7.  Counting the global COVID-19 dead.

Authors:  Prabhat Jha; Patrick E Brown; Rashid Ansumana
Journal:  Lancet       Date:  2022-05-06       Impact factor: 202.731

8.  Regional excess mortality during the 2020 COVID-19 pandemic in five European countries.

Authors:  Garyfallos Konstantinoudis; Michela Cameletti; Virgilio Gómez-Rubio; Inmaculada León Gómez; Monica Pirani; Gianluca Baio; Amparo Larrauri; Julien Riou; Matthias Egger; Paolo Vineis; Marta Blangiardo
Journal:  Nat Commun       Date:  2022-01-25       Impact factor: 14.919

9.  COVID-19 Risk Appears to Vary Across Different Alcoholic Beverages.

Authors:  Xi-Jian Dai; Liang Tan; Lina Ren; Yuan Shao; Weiqun Tao; Yongjun Wang
Journal:  Front Nutr       Date:  2022-01-03

10.  COVID-19 and Acute Coronary Syndrome: Lessons for Everyone.

Authors:  Chor-Cheung Frankie Tam; David Siu; Hung Fat Tse
Journal:  Lancet Reg Health West Pac       Date:  2021-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.